Equities

Krystal Biotech Inc

Krystal Biotech Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)199.61
  • Today's Change14.16 / 7.64%
  • Shares traded416.32k
  • 1 Year change+95.22%
  • Beta0.7979
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, Krystal Biotech Inc increased its cash reserves by 121.33%, or 196.43m. Cash Flow from Financing totalled 202.75m or 399.91% of revenues. In addition the company used 88.80m for operations while cash from investing totalled 82.64m.
Cash flow per share2.02
Price/Cash flow per share96.63
Book value per share30.80
Tangible book value per share30.80
More ▼

Balance sheet in USDView more

Krystal Biotech Inc has a strong Balance Sheet and has consistently grown its cash reserves over the last Four years to total 358.33m.
Current ratio7.97
Quick ratio7.76
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.